DEA Extends COVID-19 Teleprescribing Flexibilities through December 2024

By:

The Drug Enforcement Administration (DEA) on October 6, 2023 issued a temporary rule extending COVID-19 telemedicine flexibilities for prescribing of controlled medications through December 31, 2024, which is the current date for expiration of other telemedicine-related flexibilities. Prior to issuance of this temporary rule those flexibilities would have expired for new patients on November 11, […]

Read More

OASIS-D Instrument Use Extended

By:

On November 23, 2021 the Office of Management and Budget (OMB) approved the extension for the continued use of the Outcome and Assessment Information Set (OASIS)-D instrument with a new expiration date of November 23, 2024. Providers collecting OASIS on paper may use up any current inventory prior to using the instruments with the updated […]

Read More

OIG Adds 2 Home Health Items to Work Plan

By:

The Office of Inspector General (OIG) has announced two new items of interest to NAHC home health members. One is an audit of home health telehealth services during the COVID-19 public health emergency (PHE) and the second is a report on the challenges faced by home health agencies in responding to the PHE and the […]

Read More